A complete application in a minute
Tailored resume and cover letter, ready to send.
Convatec is seeking a commercially driven Account Manager for Ostomy Care in Scotland/North Ireland to grow the business across the territory by building trusted relationships with NHS clinical stakeholders and patients.
You will travel regularly across the territory and work with the clinical and commercial teams to deliver value-based solutions and meet sales targets.
Are you a commercially driven sales professional who enjoys building trusted relationships and making a difference for healthcare professionals and patients?
Join Convatec as an Account Manager, Ostomy Care in Scotland/North Ireland and take ownership of growing our business across your territory. You will work closely with NHS clinical stakeholders across acute and primary care, helping customers understand how Convatec’s products and services can support better outcomes.
This is a field-based role requiring regular travel across the territory, with occasional overnight stays.
You are a proactive and results-driven salesperson who enjoys building relationships, identifying opportunities and turning customer insights into action.
Convatec provides equal employment opportunities for all current employees and applicants for employment. This policy means that no one will be discriminated against because of race, religion, creed, color, national origin, nationality, citizenship, ancestry, sex, age, marital status, physical or mental disability, affectional or sexual orientation, gender identity, military or veteran status, genetic predisposing characteristics or any other basis prohibited by law.
Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With over 10,000 colleagues, we provide products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention, treatment for hard to heal wounds, at-risk skin and ulcerated tissue to supporting debilitating conditions, improved patient outcomes and reduced care costs. Convatec’s revenues in 2025 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit: http://www.convatecgroup.com.